Nomura Asset Management Co. Ltd. raised its stake in DaVita HealthCare Partners Inc. (NYSE:DVA) by 29.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 79,185 shares of the company’s stock after buying an additional 18,200 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in DaVita HealthCare Partners were worth $5,232,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. First Quadrant L P CA acquired a new position in DaVita HealthCare Partners during the second quarter valued at approximately $286,000. Checchi Capital Advisers LLC increased its position in shares of DaVita HealthCare Partners by 2.4% in the second quarter. Checchi Capital Advisers LLC now owns 1,556 shares of the company’s stock worth $120,000 after buying an additional 37 shares during the last quarter. CIBC World Markets Inc. increased its position in shares of DaVita HealthCare Partners by 52.2% in the second quarter. CIBC World Markets Inc. now owns 19,717 shares of the company’s stock worth $1,525,000 after buying an additional 6,763 shares during the last quarter. Daiwa Securities Group Inc. increased its position in shares of DaVita HealthCare Partners by 5.3% in the second quarter. Daiwa Securities Group Inc. now owns 4,000 shares of the company’s stock worth $309,000 after buying an additional 200 shares during the last quarter. Finally, MSI Financial Services Inc increased its position in shares of DaVita HealthCare Partners by 39.2% in the second quarter. MSI Financial Services Inc now owns 14,556 shares of the company’s stock worth $1,126,000 after buying an additional 4,101 shares during the last quarter. Institutional investors and hedge funds own 83.08% of the company’s stock.

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Shares of DaVita HealthCare Partners Inc. (NYSE:DVA) traded up 0.93% on Friday, hitting $64.00. 323,511 shares of the stock were exchanged. The firm has a market cap of $12.63 billion, a price-to-earnings ratio of 18.65 and a beta of 1.04. DaVita HealthCare Partners Inc. has a one year low of $54.50 and a one year high of $78.77. The firm’s 50 day moving average price is $64.59 and its 200 day moving average price is $66.53.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $0.95 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.93 by $0.02. The business earned $3.73 billion during the quarter, compared to analyst estimates of $3.72 billion. DaVita HealthCare Partners had a net margin of 4.92% and a return on equity of 16.16%. The business’s revenue was up 5.8% on a year-over-year basis. During the same period last year, the business earned $1.12 EPS. Equities analysts anticipate that DaVita HealthCare Partners Inc. will post $3.76 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another site, it was copied illegally and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be accessed at http://www.watchlistnews.com/nomura-asset-management-co-ltd-increases-stake-in-davita-healthcare-partners-inc-dva/1060017.html.

DVA has been the subject of a number of analyst reports. Wells Fargo & Company reiterated an “outperform” rating on shares of DaVita HealthCare Partners in a research note on Tuesday, November 1st. Zacks Investment Research upgraded shares of DaVita HealthCare Partners from a “strong sell” rating to a “hold” rating in a research note on Friday, November 4th. Bank of America reiterated a “hold” rating and set a $68.00 target price on shares of DaVita HealthCare Partners in a research note on Monday, November 21st. Raymond James Financial, Inc. upgraded shares of DaVita HealthCare Partners from a “market perform” rating to an “outperform” rating and set a $75.00 target price for the company in a research note on Tuesday, September 20th. Finally, SunTrust Banks, Inc. set a $66.00 target price on shares of DaVita HealthCare Partners and gave the stock a “hold” rating in a research note on Thursday, October 13th. Ten analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $74.00.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

5 Day Chart for NYSE:DVA

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.